SC 13G

Company

Esperion Therapeutics, Inc.

Filed

March 27, 2015

Accession Number

0001193125-15-109374

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →